News
Careers
Contact us
Products & services
IGX Platform
Antibody Discovery Module
IGX Platform Apps
IGXperience Program
IGX Service
Technology
Repertoire sequencing
B and T cell repertoires
Workflows
Single-cell sequencing
Data analysis
Clone annotation
Downstream analysis
Research & applications
Areas of interest
Immuno-oncology
Cancer vaccines
Autoimmunity
Infectious diseases
Transplantation
Immune system research
Applications
In basic research
In translational research
In clinical research
Our research
Company
About us
The ENPICOM dream
Mission and vision
The team
Investors
Partnerships
Careers
News
Events
Contact
Knowledge center
Resources
Publications
Scientific posters
Scientific presentations
Webinars
White papers
FAQ
Glossary
News
Careers
Contact us
Request a demo
Enpicom
News
All
Genovac further enhances its antibody discovery services with the ENPICOM IGX Platform
Read more
ENPICOM increases speed and scalability in antibody discovery with Amazon Web Services (AWS)
Read more
Ted Kloosterman joins ENPICOM as Head of Commerce
Read more
ENPICOM secures Series B funding to scale up operations to meet the high demand for its antibody discovery SaaS Platform
Read more
Bringing accurate liability assessments to antibody discovery with the IGX Platform
Read more
2021 highlights: ENPICOM’s year in review
Read more
Meet IGX Platform 3.1: More flexibility and control for your seamless Rep-Seq analysis workflow
Read more
ENPICOM participates in Inno4vac, a European new public-private partnership to innovate vaccine development
Read more
From sample to discovery: Advancing your research with full-service immune repertoire sequencing & analysis
Read more
ENPICOM introduces a powerful liability prediction solution to de-risk antibody development
Read more
ENPICOM is featured among the top 50 fastest growing Data Science SMEs in the Netherlands
Read more
ENPICOM to integrate renowned structural antibody prediction tools developed at the University of Oxford
Read more
Empowering research teams: The path to accessible immune repertoire data
Read more
Zai Lab selects ENPICOM’s IGX Platform to leverage new NGS-powered antibody discovery workflows
Read more
The impact of high-throughput immune repertoire sequencing on the analysis of antibody responses: A conversation with Prof. Gunilla Karlsson Hedestam of Karolinska Institute
Read more
Phylogenetic analysis of BCR repertoires: Benefits, challenges, and considerations
Read more
Webinar: Understanding the role of B cells in cancer through antibody repertoire analysis
Read more
Breaking the UX barrier: Towards user-focused biomedical software
Read more
ENPICOM and Viroclinics-DDL receive joint MIT R&D ZH subsidy to accelerate and improve antibody and vaccine discovery and development
Read more
ENPICOM joins the MIRIADE consortium
Read more
On-demand webinar: Presenting the new Antibody Discovery Module
Read more
Gillian O’Halloran joins ENPICOM as Chief Operating Officer
Read more
Introducing the IGX Platform 3.0
Read more
ENPICOM introduces an end-to-end solution for fast and efficient antibody discovery
Read more
Wrapping up 2020: ENPICOM milestones, events, and innovations in review
Read more
ENPICOM and MiLaboratories join forces to power better Repertoire Sequencing data management and analysis workflows
Read more
ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution
Read more
Introducing the IGXperience Program
Read more
ENPICOM is now a corporate sponsor of The Antibody Society
Read more
Single-cell sequencing: Industry trends and developments
Read more
University Health Network, Canada’s largest research hospital, selects ENPICOM’s IGX Platform to analyze and manage immune sequencing data
Read more
Introducing the IGX Platform 2.1
Read more
Gaining a deeper understanding of the immune system: A conversation with Prof. Dirk Busch and Dr. Kilian Schober of the Technical University of Munich
Read more
Fighting COVID-19 and transforming infectious disease research with immune repertoire sequencing
Read more
More data from a single cell: Advancing your immunology research with Repertoire Sequencing
Read more
Single-cell and beyond: How to better exploit paired-chain immune repertoire data
Read more
On-demand webinar: Maximize your Rep-Seq data output with an end-to-end platform
Read more
ENPICOM receives a €1.13 million follow-on investment
Read more
ENPICOM is one of the top 50 fastest growing Data Science SMEs in the Netherlands
Read more
ENPICOM deepens insights into the immune system enabling faster precision medicine development and pandemic prevention
Read more
2019 highlights: ENPICOM’s year in review
Read more
ENPICOM and Cytura Therapeutics partner on early cancer detection
Read more
Introducing IGX Platform 1.1
Read more
ENPICOM has been featured as one of the 20 cutting-edge tech companies of 2019
Read more
ENPICOM opens satellite office in Science Park Amsterdam
Read more
ENPICOM has been recognized as one of the 15 most promising biotech startups in Europe in 2019
Read more
Introducing the IGX Platform to the AIRR Community
Read more
DDL diagnostic laboratory and ENPICOM join forces
Read more
ENPICOM launches unique immune sequencing data analysis platform
Read more
ENPICOM secures funding round to finalize IGX Platform development
Read more
Survey results: European immunotherapy companies have great concerns regarding increasing costs and long development timelines
Read more
ENPICOM sets a new standard for B cell receptor repertoire analysis
Read more
Towards a predictable combination therapy for multiple cancer types
Read more
New scientific presentation: Accelerate your immunotherapy target discovery using immune repertoire sequencing
Read more
ENPICOM team wins Microsoft Genomics Hackathon
Read more
Scientific poster from UKE/ENPICOM receives award at annual meeting of DGHO
Read more
ENPICOM presents at World Immunotherapy Congress 2018
Read more
CSO of ENPICOM gives keynote lecture at ByteMAL Conference 2018
Read more
ENPICOM receives Eurostars award
Read more
ENPICOM releases immune repertoire sequencing analysis platform to personalize immunotherapies
Read more
EUROSTARS grants project funding for IMMUNOMONITOR consortium led by ENPICOM
Read more
ENPICOM at the 17th CIMT Annual Meeting in Mainz, Germany
Read more
ENPICOM at BioSB 2018, 4th Dutch Bioinformatics & System Biology Conference
Read more
ENPICOM featured in GenomeWeb, world’s leading life science technology news outlet
Read more
With new CEO ENPICOM enters its next phase
Read more
ISMB2017 / ECCB2017 in Prague
Read more
Amsterdam Data Science event
Read more
BioSB 2017 in Lunteren
Read more
RSG Symposium on Computational Genomics in Mainz, Germany
Read more
ENPICOM joins the Dutch TechCentre for Life Sciences
Read more
Load more news